TrialCritical care (London, England)2021

Impact of rewarming rate on interleukin-6 levels in patients with shockable cardiac arrest receiving targeted temperature management at 33 °C: the ISOCRATE pilot randomized controlled trial.

Jean-Baptiste Lascarrou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.